Federal Register / Vol. 65, No. 193 / Wednesday, October 4, 2000 / Notices 59257

1See Adrian & Blissfield Rail Road CompanyAcquisition Exemption-Grand Trunk Western

Railroad Incorporated, STB Finance Docket No.

33692 (STB served Dec. 28, 1998).

1See Adrian & Blissfield Rail Road CompanyAcquisition Exemption-Grand Trunk Western

Railroad Incorporated, STB Finance Docket No.

33718 (STB served Mar. 3, 1999).

DEPARTMENT OF TRANSPORTATION

Surface Transportation Board

[STB Finance Docket No. 33935]

Detroit Connecting Railroad

Company—Acquisition and Operation

Exemption—Adrian & Blissfield Rail

Road Company

Detroit Connecting Railroad Company

(DCON), a noncarrier, has filed a notice

of exemption under 49 CFR 1150.31 to

acquire and operate approximately 2.27

miles of rail line owned by Adrian &

Blissfield Rail Road Company. The line,

known as the ‘‘Dequindre Line,’’ is part

of Grand Trunk Western Railroad

Incorporated’s Holly Subdivision at

Detroit, Wayne County, MI, and runs

between milepost 1.77 and milepost

4.04. 1 DCON certifies that its projected

revenues as a result of this transaction

will not result in the creation of a Class

II or Class I rail carrier, and further

certifies that its projected annual

revenues will not exceed $5 million.

The transaction is expected to be

consummated on or shortly after

September 28, 2000.

If the notice contains false or

misleading information, the exemption

is void ab initio. Petitions to revoke the

exemption under 49 U.S.C. 10502(d)

may be filed at any time. The filing of

a petition to revoke will not

automatically stay the transaction.

An original and 10 copies of all

pleadings, referring to STB Finance

Docket No. 33935, must be filed with

the Surface Transportation Board, Office

of the Secretary, Case Control Unit, 1925

K Street, NW., Washington, DC 20423–

0001. In addition, a copy of each

pleading must be served on Kenneth J.

Bisdorf, 2301 West Big Beaver Road,

Suite 600, Troy, MI 48084–3329.

Board decisions and notices are

available on our website at

‘‘WWW.STB.DOT.GOV.’’

Decided: September 26, 2000.

By the Board, David M. Konschnik,

Director, Office of Proceedings.

Vernon A. Williams,

Secretary.

[FR Doc. 00–25245 Filed 10–4–00; 8:45 am]

BILLING CODE 4915–00–P

DEPARTMENT OF TRANSPORTATION

Surface Transportation Board

[STB Finance Docket No. 33937]

Charlotte Southern Railroad CompanyAcquisition and Operation ExemptionAdrian & Blissfield Rail Road Company

Charlotte Southern Railroad Company

(CHS), a noncarrier, has filed a notice of

exemption under 49 CFR 1150.31 to

acquire and operate approximately 3.22

miles of rail line owned by Adrian &

Blissfield Rail Road Company. The line,

known as the ‘‘Charlotte Spur,’’ is part

of Grand Trunk Western Railroad

Incorporated’s Flint Subdivision at

Charlotte, Eaton County, MI, and runs

between milepost 21.24 and milepost

24.46.1 CHS certifies that its projected

revenues as a result of this transaction

will not result in the creation of a Class

II or Class I rail carrier, and further

certifies that its projected annual

revenues will not exceed $5 million.

The transaction is expected to be

consummated on or shortly after

September 28, 2000.

If the notice contains false or

misleading information, the exemption

is void ab initio. Petitions to revoke the

exemption under 49 U.S.C. 10502(d)

may be filed at any time. The filing of

a petition to revoke will not

automatically stay the transaction.

An original and 10 copies of all

pleadings, referring to STB Finance

Docket No. 33937, must be filed with

the Surface Transportation Board, Office

of the Secretary, Case Control Unit, 1925

K Street, N.W., Washington, DC 20423–

0001. In addition, a copy of each

pleading must be served on Kenneth J.

Bisdorf, 2301 West Big Beaver Road,

Suite 600, Troy, MI 48084–3329.

Board decisions and notices are

available on our website at

‘‘WWW.STB.DOT.GOV.’’

Decided: September 26, 2000.

By the Board, David M. Konschnik,

Director, Office of Proceedings.

Vernon A. Williams,

Secretary.

[FR Doc. 00–25246 Filed 10–3–00; 8:45 am]

BILLING CODE 4915–00–P

DEPARTMENT OF THE TREASURY

Office of Thrift Supervision

[AC–2: OTS Nos. H–2241, H–3609 and

07874]

Finger Lakes Bancorp, Inc., Geneva,

New York; and Savings Bank of the

Finger Lakes, Geneva, New York;

Approval of Conversion Application

Notice is hereby given that on

September 28, 2000, the Managing

Director, Office of Supervision, Office of

Thrift Supervision, or his designee,

acting pursuant to delegated authority,

approved the application of Finger

Lakes Bancorp, Inc., Geneva, New York,

and Savings Bank of the Finger Lakes,

Geneva, New York, to convert to the

stock form of organization. Copies of the

application are available for inspection

at the Dissemination Branch, Office of

Thrift Supervision, 1700 G Street, NW.,

Washington, DC 20552, and the

Northeast Regional Office, Office of

Thrift Supervision, 10 Exchange Place,

18th Floor, Jersey City, New Jersey

07302.

Dated: September 29, 2000.

By the Office of Thrift Supervision.

Nadine Y. Washington,

Corporate Secretary.

[FR Doc. 00–25451 Filed 10–3–00; 8:45 am]

BILLING CODE 6720–01–M

DEPARTMENT OF VETERANS

AFFAIRS

Research and Development

Cooperative Studies Evaluation

Committee; Notice of Meeting

The Department of Veterans Affairs

gives notice under Public Law 92–463

(Federal Advisory Committee Act) as

amended, by section 5(C) of Public Law

94–409, that a meeting of the Research

and Development Cooperative Studies

Evaluation Committee will be held at

The Madison Hotel, 15th & M Street

NW, Washington, DC 20005, October

11–12, 2000. This session is scheduled

to begin at 7:30 a.m. and end at 5 p.m.

The meeting will be for the purpose of

reviewing the following three new

proposals: A Randomized Clinical Trial

of Cognitive-Behavioral Treatment for

PTSD in Women Veterans, Heart Failure

in Patients with Preserved Systolic

Function, and Tri-National Study—

Optimal Management of Patients with

HIV Infection of Whom 1st and 2nd

Line Highly Active Anti-Retroviral

Therapy Has Failed (OPTIMA).

The Committee advises the Chief

Research and Development Officer